|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2003-10-21
|
|
pubmed:abstractText |
To examine whether the small quantities of lipid present in unit-dose microemulsion formulations comprising medium- (C8-10) or long-chain (C18) glyceride lipids can stimulate the intestinal lymphatic transport of halofantrine (Hf), a model lymphatically transported drug.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0724-8741
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1460-5
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14567642-Absorption,
pubmed-meshheading:14567642-Administration, Oral,
pubmed-meshheading:14567642-Animals,
pubmed-meshheading:14567642-Biological Transport,
pubmed-meshheading:14567642-Chemistry, Pharmaceutical,
pubmed-meshheading:14567642-Dogs,
pubmed-meshheading:14567642-Drug Carriers,
pubmed-meshheading:14567642-Emulsions,
pubmed-meshheading:14567642-Fasting,
pubmed-meshheading:14567642-Intestines,
pubmed-meshheading:14567642-Lipids,
pubmed-meshheading:14567642-Lymphatic System,
pubmed-meshheading:14567642-Phenanthrenes,
pubmed-meshheading:14567642-Time Factors
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogs.
|
|
pubmed:affiliation |
Department of Pharmaceutics, Victorian College of Pharmacy, Monash University, Parkville, Victoria 3052, Australia.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
